NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis → Bombshell 2024 election documentary (From Porter & Company) (Ad) Free PIII Stock Alerts $1.03 +0.01 (+0.98%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$1.00▼$1.1250-Day Range$0.71▼$1.2152-Week Range$0.66▼$5.56Volume397,444 shsAverage Volume437,683 shsMarket Capitalization$322.48 millionP/E RatioN/ADividend YieldN/APrice Target$4.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get P3 Health Partners alerts: Email Address P3 Health Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside361.2% Upside$4.75 Price TargetShort InterestHealthy4.29% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.24Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.98) to ($0.54) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.00 out of 5 starsMedical Sector623rd out of 939 stocksHealth Services Industry6th out of 10 stocks 3.3 Analyst's Opinion Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.75, P3 Health Partners has a forecasted upside of 361.2% from its current price of $1.03.Amount of Analyst CoverageP3 Health Partners has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.29% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 10.48%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PIII. Previous Next 1.8 News and Social Media Coverage News SentimentP3 Health Partners has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for P3 Health Partners this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for PIII on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders17.06% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.98) to ($0.54) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 6.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyBombshell 2024 election documentary 2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.All the facts are here. About P3 Health Partners Stock (NASDAQ:PIII)P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.Read More PIII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PIII Stock News HeadlinesMarch 28, 2024 | benzinga.comP3 Health Partners: Q4 Earnings InsightsMarch 28, 2024 | finance.yahoo.comP3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net LossMarch 29, 2024 | Porter & Company (Ad)Bombshell 2024 election documentary 2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.March 28, 2024 | businesswire.comP3 Health Partners Announces Fourth Quarter and Full Year 2023 ResultsMarch 26, 2024 | americanbankingnews.comP3 Health Partners (PIII) to Release Earnings on ThursdayMarch 25, 2024 | americanbankingnews.comAgape ATP (NASDAQ:ATPC) and P3 Health Partners (NASDAQ:PIII) Critical SurveyMarch 21, 2024 | americanbankingnews.comP3 Health Partners (PIII) Set to Announce Earnings on ThursdayMarch 17, 2024 | uk.investing.comP3 Health to report Q4 and full year 2023 earnings on March 28March 29, 2024 | Porter & Company (Ad)Bombshell 2024 election documentary 2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.February 28, 2024 | businesswire.comP3 Health Partners to Participate in the Jefferies Value Based Healthcare SummitFebruary 19, 2024 | businesswire.comP3 Health Partners to Present at the TD Cowen 44th Annual Healthcare ConferenceJanuary 30, 2024 | finance.yahoo.comP3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 19, 2024 | finance.yahoo.comP3 Health Partners Inc.'s (NASDAQ:PIII) Path To ProfitabilityJanuary 10, 2024 | msn.comP3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimatesJanuary 10, 2024 | markets.businessinsider.comWhy Health Management Company P3 Health Partners Shares Are Up TodayJanuary 9, 2024 | markets.businessinsider.comP3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock UpJanuary 9, 2024 | finance.yahoo.comP3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024January 2, 2024 | finance.yahoo.comP3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2023 | morningstar.comP3 Health Partners Inc Class A PIIINovember 15, 2023 | markets.businessinsider.comPositive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen’s Buy Rating for P3 Health PartnersNovember 12, 2023 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | businesswire.com55,508November 8, 2023 | finance.yahoo.comP3 Health Partners Announces Third-Quarter and Year-to-Date 2023 ResultsNovember 3, 2023 | finance.yahoo.comP3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference CallOctober 29, 2023 | finance.yahoo.comSeveral Insiders Invested In P3 Health Partners Flagging Positive NewsOctober 20, 2023 | money.usnews.comP3 Health Partners Inc - Ordinary Shares - Class AOctober 6, 2023 | uk.investing.comP3 Health Partners Recent Insider ActivitySee More Headlines Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees600Year FoundedN/APrice Target and Rating Average Stock Price Target$4.75 High Stock Price Target$5.00 Low Stock Price Target$4.50 Potential Upside/Downside+361.2%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($2,260.6599) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-270,130,000.00 Net Margins-10.73% Pretax Margin-54.92% Return on Equity2,454.69% Return on Assets37.99% Debt Debt-to-Equity Ratio0.58 Current Ratio0.67 Quick Ratio0.67 Sales & Book Value Annual Sales$1.05 billion Price / Sales0.31 Cash Flow$51.50 per share Price / Cash Flow0.02 Book Value$0.15 per share Price / Book6.87Miscellaneous Outstanding Shares313,090,000Free Float259,676,000Market Cap$322.48 million OptionableNot Optionable Beta1.05 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Sherif Abdou F.A.C.E.P. (Age 63)FACP, M.D., Co-Founder, CEO & Director Comp: $7.1MDr. Amir Bacchus M.B.A. (Age 59)M.D., Co-Founder, Chief Medical Officer & Director Comp: $4.3MMr. Atul KavthekarCFO & Chief Accounting OfficerMr. William BettermannExecutive VP & COOMr. Devery GoodeySenior Vice President of TechnologyRoy YoungbloodDirector of ComplianceMs. Kassi Belz APRExecutive Vice President of Communications, Culture & EngagementMr. Todd Lefkowitz MHAChief Managed Care OfficerMs. Sarah Bussmann B.S.N.CRNI, M.H.A., R.N., Chief of StaffMr. David YargerMarket President of Arizona MarketMore ExecutivesKey CompetitorsSharecareNASDAQ:SHCROrion Biotech OpportunitiesNASDAQ:ORIAGlobal Consumer AcquisitionNASDAQ:GACQGeneDxNASDAQ:WGSDocGoNASDAQ:DCGOView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 1,016,605 shares on 3/11/2024Ownership: 0.498%GSA Capital Partners LLPBought 169,140 shares on 2/16/2024Ownership: 0.086%Vanguard Group Inc.Sold 1,016,605 shares on 2/15/2024Ownership: 0.498%Nuveen Asset Management LLCBought 14,018 shares on 2/15/2024Ownership: 0.055%Barclays PLCBought 48,939 shares on 2/15/2024Ownership: 0.018%View All Insider TransactionsView All Institutional Transactions PIII Stock Analysis - Frequently Asked Questions Should I buy or sell P3 Health Partners stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PIII shares. View PIII analyst ratings or view top-rated stocks. What is P3 Health Partners' stock price target for 2024? 3 brokers have issued 12-month price targets for P3 Health Partners' stock. Their PIII share price targets range from $4.50 to $5.00. On average, they expect the company's share price to reach $4.75 in the next year. This suggests a possible upside of 361.2% from the stock's current price. View analysts price targets for PIII or view top-rated stocks among Wall Street analysts. How have PIII shares performed in 2024? P3 Health Partners' stock was trading at $1.41 on January 1st, 2024. Since then, PIII stock has decreased by 27.0% and is now trading at $1.03. View the best growth stocks for 2024 here. When is P3 Health Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our PIII earnings forecast. What guidance has P3 Health Partners issued on next quarter's earnings? P3 Health Partners updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.4 billion. Who are P3 Health Partners' major shareholders? P3 Health Partners' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (0.50%), Vanguard Group Inc. (0.50%), Northern Trust Corp (0.10%), GSA Capital Partners LLP (0.09%), Nuveen Asset Management LLC (0.05%) and Barclays PLC (0.02%). Insiders that own company stock include Atul Kavthekar, Michael Balkin, Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago and Sherif Abdou. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PIII) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss Ratings“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.